# An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)

> **NCT01697488** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1090 (actual)

## Conditions studied

- Peritoneal Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01697488
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-02
- **Primary completion:** 2019-09-27
- **Final completion:** 2019-09-27
- **Target enrollment:** 1090 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697488, "An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01697488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*